日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Brief Report: Exploratory Substudy of a Phase 2 Trial to Evaluate the Pharmacokinetic Effect of Once-Monthly Islatravir on Long-Acting Reversible Contraceptives

简报：一项评估每月一次注射伊斯拉曲韦对长效可逆避孕药药代动力学影响的 II 期试验的探索性子研究

期刊:Jaids-Journal of Acquired Immune Deficiency Syndromes
影响因子:
doi:10.1097/QAI.0000000000003678
Pham, Michelle; Wickremasingha, Prachi; Vargo, Ryan; Patel, Munjal; Nedrow, Katherine; Homony, Brenda; Robertson, Michael N; Plank, Rebeca M
发表日期：2025
文献求助 收藏

Safety, Tolerability, and Pharmacokinetics of Once-Monthly Oral Islatravir: A Phase 2a Study in Participants at Low Risk for Acquiring Human Immunodeficiency Virus Type 1

每月一次口服伊斯拉曲韦的安全性、耐受性和药代动力学：一项针对1型人类免疫缺陷病毒感染低风险人群的2a期研究

期刊:Journal of Infectious Diseases
影响因子:
doi:10.1093/infdis/jiaf222
Hillier, Sharon L; Bekker, Linda-Gail; Riddler, Sharon A; Hendrix, Craig W; Badal-Faesen, Sharlaa; Macdonald, Pippa; Nair, Gonasagrie; Lombaard, Johannes; Caraco, Yoseph; Peer, Avivit; Patel, Munjal; Vargo, Ryan; Homony, Brenda; Nedrow, Katherine; Evans, Barbara; Wickremasingha, Prachi; Zhou, Yun-Ping; Teal, Valerie; Hwang, Peggy; McMullan, Ciaran; Kaufman, Keith D; Robertson, Michael N; Plank, Rebeca M
HIV
炎症/感染
微生物学
Human
免疫/内分泌
发表日期：2025
文献求助 收藏

A Health Literate Patient-focused Approach to the Redesign of the Raltegravir (ISENTRESS) Pediatric Kit and Instructions for Use

以健康素养高的患者为中心，重新设计拉替拉韦（ISENTRESS）儿科试剂盒和使用说明

期刊:Pediatric Infectious Disease Journal
影响因子:2.2
doi:10.1097/INF.0000000000003334
Mills, Alexander; Myers, Laurie; Raudenbush, Casey; Vossen, David A; Teppler, Hedy; Miteva, Yanna R; Seeley, Suzanne; Homony, Brenda; Straus, Walter L
发表日期：2022
文献求助 收藏

Safety and efficacy at 240 weeks of different raltegravir formulations in children with HIV-1: a phase 1/2 open label, non-randomised, multicentre trial

不同拉替拉韦制剂在 HIV-1 感染儿童中 240 周的安全性和有效性：一项 1/2 期开放标签、非随机、多中心试验

期刊:Lancet HIV
影响因子:13
doi:10.1016/S2352-3018(18)30257-1
Nachman, Sharon; Alvero, Carmelita; Teppler, Hedy; Homony, Brenda; Rodgers, Anthony J; Graham, Bobbie L; Fenton, Terence; Frenkel, Lisa M; Browning, Renee S; Hazra, Rohan; Wiznia, Andrew A
HIV
炎症/感染
微生物学
发表日期：2018
文献求助 收藏

Pharmacokinetics and 48-Week Safety and Efficacy of Raltegravir for Oral Suspension in Human Immunodeficiency Virus Type-1-Infected Children 4 Weeks to 2 Years of Age

拉替拉韦口服混悬液在4周至2岁感染1型人类免疫缺陷病毒的儿童中的药代动力学、48周安全性和有效性研究

期刊:Journal of the Pediatric Infectious Diseases Society
影响因子:2.6
doi:10.1093/jpids/piu146
Nachman, Sharon; Alvero, Carmelita; Acosta, Edward P; Teppler, Hedy; Homony, Brenda; Graham, Bobbie; Fenton, Terence; Xu, Xia; Rizk, Matthew L; Spector, Stephen A; Frenkel, Lisa M; Worrell, Carol; Handelsman, Edward; Wiznia, Andrew
HIV
炎症/感染
微生物学
Human
免疫/内分泌
发表日期：2015
文献求助 收藏

Population pharmacokinetic analysis of raltegravir pediatric formulations in HIV-infected children 4 weeks to 18 years of age

对4周至18岁HIV感染儿童使用拉替拉韦儿科制剂进行群体药代动力学分析

期刊:Journal of Clinical Pharmacology
影响因子:2.3
doi:10.1002/jcph.493
Rizk, Matthew L; Du, Lihong; Bennetto-Hood, Chantelle; Wenning, Larissa; Teppler, Hedy; Homony, Brenda; Graham, Bobbie; Fry, Carrie; Nachman, Sharon; Wiznia, Andrew; Worrell, Carol; Smith, Betsy; Acosta, Edward P
HIV
炎症/感染
微生物学
发表日期：2015
文献求助 收藏

Pharmacokinetics, safety, and 48-week efficacy of oral raltegravir in HIV-1-infected children aged 2 through 18 years

口服拉替拉韦在2至18岁HIV-1感染儿童中的药代动力学、安全性和48周疗效

期刊:Clinical Infectious Diseases
影响因子:7.3
doi:10.1093/cid/cit696
Nachman, Sharon; Zheng, Nan; Acosta, Edward P; Teppler, Hedy; Homony, Brenda; Graham, Bobbie; Fenton, Terence; Xu, Xia; Wenning, Larissa; Spector, Stephen A; Frenkel, Lisa M; Alvero, Carmelita; Worrell, Carol; Handelsman, Edward; Wiznia, Andrew
HIV
炎症/感染
微生物学
发表日期：2014
文献求助 收藏